Nan Fung Group Holdings’s Madrigal Pharmaceuticals MDGL Stock Holding History

Nan Fung Group Holdings’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.05M	Hold	5,672	–	–	2.32%	12
2026 Q1	$2.97M	Sell	5,672 -6,200	-52%	-$2.96M	2.45%	11
2025 Q4	$6.91M	Hold	11,872	–	–	6.19%	4
2025 Q3	$5.45M	Hold	11,872	–	–	9.13%	2
2025 Q2	$3.59M	Hold	11,872	–	–	5.66%	6
2025 Q1	$3.93M	Buy	11,872 +750	+7%	+$246K	3.21%	13
2024 Q4	$3.43M	Buy	11,122 +1,360	+14%	+$383K	2.94%	16
2024 Q3	$2.07M	Buy	9,762 +4,080	+72%	+$1.04M	1.78%	19
2024 Q2	$1.59M	Hold	5,682	–	–	1.7%	20
2024 Q1	$1.52M	Buy	5,682 +4,500	+381%	+$1.06M	1.41%	22
2023 Q4	$273K	Buy	+1,182	New	+$207K	0.17%	32
2023 Q3	–	Sell	-1,182	Closed	-$273K	–	41
2023 Q2	$273K	Hold	1,182	–	–	0.17%	35
2023 Q1	$286K	Hold	1,182	–	–	0.19%	35
2022 Q4	$343K	Buy	+1,182	New	+$116K	0.24%	34

Other funds holding MDGL

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nan Fung Group Holdings's MDGL Position: Q2 2026 in Review

Nan Fung Group Holdings held its Madrigal Pharmaceuticals (MDGL) position steady in Q2 2026 at 5,672 shares worth $3.05M. The position accounts for 2.32% of the portfolio, ranked #12.

Nan Fung Group Holdings first reported a position in MDGL in Q4 2022 and has held it in 14 quarters since. The position peaked at $6.91M in Q4 2025. 413 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

Nan Fung Group Holdings held 5,672 shares of Madrigal Pharmaceuticals worth $3.05M as of Q2 2026.
Nan Fung Group Holdings left its Madrigal Pharmaceuticals share count unchanged in Q2 2026.
Madrigal Pharmaceuticals made up 2.32% of Nan Fung Group Holdings's portfolio in Q2 2026, its #12 holding.
Nan Fung Group Holdings first reported a position in Madrigal Pharmaceuticals in Q4 2022 and has held it in 14 quarters since.
Nan Fung Group Holdings's Madrigal Pharmaceuticals position peaked at $6.91M in Q4 2025.
413 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Nan Fung Group Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.